Overview Fundamentals API Earnings EOD API Sample Code Pricing

Cara Therapeutic (CARA NASDAQ) stock market data APIs

$0.35 0.01(2.9%) as of July 19, 2024
Price chart is built with Anychart

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

Cara Therapeutic Financial Data Overview

0.3445
0.35
-
0.3549
0.338
0.24-3.45
18 836 K
54 676 K
16 938 K
-0.56
0.687
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CARA',
Type: 'Common Stock',
Name: 'Cara Therapeutic',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG001J2QYS9',
ISIN: NULL,
CUSIP: NULL,
CIK: '1346830',
EmployerIdNumber: '75-3175693',
FiscalYearEnd: 'December',
IPODate: '2014-01-31',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Cara Therapeutic Fundamental Data is available in our Financial Data APIs

  • Net Revenue 16 938 K
  • EBITDA -120 867 000
  • Earnings Per Share -2.26
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Cara Therapeutic Earnings via APIs

  • Latest Release 2024-05-13
  • EPS/Forecast -0.4

Get Cara Therapeutic End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com